BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
New England Journal of Medicine · 12.06.2025 · 392 (22) · 2282-2284
DOI: 10.1056/nejmc2502297 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 12.06.2025. Verfasst von Lele Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, Tianjin, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, Tianjin, China.
- Blood Diseases Hospital, Tianjin, China.
ORCID-Profile: Lele Zhang
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- the National Key R&D Program of China
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Zhang, L., Gao, Z., Pan, H., Li, R., Fang, L., Li, W., Zhao, J., Yu, X., Kuang, Z., Nie, N., Li, J., Huang, J., Zhao, X., Ge, M., Zheng, Y., Luo, Y., & Shi, J. (2025). BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy. New England Journal of Medicine, 392(22), 2282-2284. https://doi.org/10.1056/nejmc2502297
Vancouver
Zhang L, Gao Z, Pan H, Li R, Fang L, Li W, et al. BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy. New England Journal of Medicine. 2025;392(22):2282-2284. doi:10.1056/nejmc2502297
BibTeX
@article{Zhang2025,
author = {Zhang, Lele and Gao, Zhen and Pan, Hong and Li, Ruonan and Fang, Liwei and Li, Weiwang and Zhao, Jingyu and Yu, Xiao and Kuang, Zhexiang and Nie, Neng and Li, Jianping and Huang, Jinbo and Zhao, Xin and Ge, Meili and Zheng, Yizhou and Luo, Yuechen and Shi, Jun},
title = {BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {22},
pages = {2282--2284},
doi = {10.1056/nejmc2502297}
}
EUVIMED